Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Despina Papakosta"'
Autor:
Ole Hilberg, Anna-Maria Hoffmann-Vold, Vanessa Smith, Demosthenes Bouros, Maritta Kilpeläinen, Julien Guiot, Antonio Morais, Susana Clemente, Zoe Daniil, Despina Papakosta, Havard Fretheim, Sofia Neves, Tiago M. Alfaro, Katerina M. Antoniou, Neus Valveny, Guus Asijee, Stéphane Soulard, Wim Wuyts
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2022)
The PERSEIDS study aimed to estimate incidence/prevalence of interstitial lung diseases (ILDs), fibrosing interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated ILD (SSc-ILD), other non-IPF F-ILDs and
Externí odkaz:
https://doaj.org/article/1b115a69fb524e58b1b59d32df69a593
Autor:
Katerina Antoniou, Katerina Markopoulou, Argyrios Tzouvelekis, Athina Trachalaki, Eirini Vasarmidi, Jiannis Organtzis, Vasilios Tzilas, Evangelos Bouros, Georgia Kounti, Christina Rampiadou, Serafeim-Chrysovalantis Kotoulas, Fotini Bardaka, Eleni Bibaki, Evangelia Fouka, Georgios Meletis, Stavros Tryfon, Zoe Daniil, Despina Papakosta, Demosthenes Bouros
Publikováno v:
ERJ Open Research, Vol 6, Iss 1 (2020)
Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated the effectiveness and safety of nintedanib in routine clinica
Externí odkaz:
https://doaj.org/article/e5ba3a4ca5ea43fcbee1820a5c1725ed
Autor:
Diamantis Almaliotis, Pavlos Michailopoulos, Dimitrios Gioulekas, Paschalina Giouleka, Despina Papakosta, Thomas Siempis, Vasileios Karampatakis
Publikováno v:
World Allergy Organization Journal, Vol 6, Iss , Pp - (2013)
Background Ocular allergies affect a great part of the general population and often co exist with other allergic manifestations. In the present study, the prevalence of allergic conjunctivitis and the commonest allergens in allergic patients at an ou
Externí odkaz:
https://doaj.org/article/676d32f10fc34e90b866ec10a17182ad
Publikováno v:
Pulmonary Medicine, Vol 2012 (2012)
Externí odkaz:
https://doaj.org/article/79160b71b9444601a6cf659a5c98d39c
Autor:
Galateia Verykokou, Despina Papakosta, Effrosyni D. Manali, Georgios Hillas, Katerina Dimakou, Stamatoula Tsikrika, Georgia Papadaki, Myrto Mplizou, Maria Kallieri, Andriana I. Papaioannou, Konstantinos Bartziokas, Spyridon Papiris, Evangelia Fouka, Stelios Loukides, Vasiliki Apollonatou, Anastasia Papaporfyriou, Evgenia Papathanasiou
Publikováno v:
Postgraduate Medicine. 133:524-529
Background and objectives: Administration of inhaled medication for asthma and COPD is often difficult and incorrect device use is associated with unfavorable outcomes. We aimed to evaluate device ...
Autor:
Theodoros Kontakiotis, Katerina Paraskevaidou, Dionisios Spyratos, Ioannis Kioumis, Konstantinos Porpodis, Despina Papakosta
Publikováno v:
Journal of Asthma. 58:170-179
Objective: The detection of asthma and rhinitis in furniture workers exposed to chemicals in the area of Thessaloniki Greece and the determination of the most useful tests for diagnosing the above ...
Autor:
Maria Kipourou, Katerina Dimakou, Sevasti Ampelioti, Michail Makris, Stylianos Loukides, Konstantinos Samitas, Konstantinos Katsoulis, Petros Bakakos, Despina Papakosta, Marija Hadji Mitrova, Spyridon Papiris, Sofia Koukidou, Miltiadis Markatos, Evangelia Fouka, Stylianos Vittorakis, Nikolaos Tzanakis, Maria Kallieri, Eleftherios Zervas, Maria Ntakoula, Andriana I. Papaioannou, Konstantinos Porpodis, Eleni Gaki, Panagiotis Lyberopoulos
Publikováno v:
Airway pharmacology and treatment.
Introduction: Μepolizumab is a monoclonal antibody against IL-5 for the treatment of severe eosinophilic asthma. The aim of the current study was to present a predesigned interim analysis of the data of patients who have completed one year of therap
Autor:
Spyridon Papiris, Aikaterini Dimakou, Myrto Mplizou, Galateia Verykokou, Effrosyni D. Manali, Stamatoula Tsikrika, Georgia Papadaki, Konstantinos Bartziokas, Anastasia Papaporfyriou, Andriana I. Papaioannou, Vasiliki Apollonatou, Maria Kallieri, Stelios Loukides, Despina Papakosta, Evangelia Fouka, Evgenia Papathanasiou, Georgios Hillas
Publikováno v:
Airway pharmacology and treatment.
Background: Incorrect use of inhaler devices is associated with unfavorable outcomes Aim: To evaluate device use errors in asthma and COPD patients treated in outpatient clinics of 3 tertiary hospitals and one private practice office in Greece Method
Autor:
Zoe Daniil, Katerina Markopoulou, Despina Papakosta, Demosthenes Bouros, Christina Rampiadou, Vasilios Tzilas, Eleni Bibaki, Evangelos Bouros, Eirini Vasarmidi, Katerina M. Antoniou, Evangelia Fouka, Georgios Meletis, Athina Trachalaki, Serafeim-Chrysovalantis Kotoulas, Georgia Kounti, Stavros Tryfon, Argyrios Tzouvelekis, Fotini Bardaka, Jiannis Organtzis
Publikováno v:
ERJ Open Research
ERJ Open Research, Vol 6, Iss 1 (2020)
ERJ Open Research, Vol 6, Iss 1 (2020)
Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated the effectiveness and safety of nintedanib in routine clinica
Autor:
Despina Papakosta, Evangelia Fouka, Theodoros Kontakiotis, Eirini Kontakioti, Konstantinos Zarogoulidis, Kalliopi Domvri, Konstantinos Porpodis
Publikováno v:
Journal of Asthma. 54:520-529
The purpose of this study was to demonstrate and compare the diagnostic validity of two bronchial challenges and to investigate their correlation with patient clinical status, atopy and inflammation markers.Eighty-eight patients, 47 women and 41 men,